Author details

Full Name

Bert Vogelstein

Affiliation

ORCID

Career Start Year

1976

Papers

608

H Index

236

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36596784	The rapid and highly parallel identification of antibodies with defined biological activities by SLISY.	Nat Commun	2023
37948357	Radiologists' Expectations of Artificial Intelligence in Pancreatic Cancer Imaging: How Good Is Good Enough?		2023
37604828	Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.		2023
37565753	The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer.	Cancer Discov	2023
37626188	Author Correction: 14-3-3Ï¿ is required to prevent mitotic catastrophe after DNA damage.	Nature	2023
37552989	Seq-ing the SINEs of central nervous system tumors in cerebrospinal fluid.	Cell Rep Med	2023
37014860	Detection of rare mutations, copy number alterations, and methylation in the same template DNA molecules.	Proc Natl Acad Sci U S A	2023
35178604	Correction to: Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.	Virchows Archiv	2022
35657320	Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.	New England Journal of Medicine	2022
35394875	TCR-mimic bispecific antibodies to target the HIV-1 reservoir.	Proc Natl Acad Sci U S A	2022
36098760	Classification of pancreatic cystic neoplasms using radiomic feature analysis is equivalent to an experienced academic radiologist: a step toward computer-augmented diagnostics for radiologists.	Abdominal Radiology	2022
35692635	An isogenic cell line panel for sequence-based screening of targeted anticancer drugs.	iScience	2022
35122030	Author Correction: Targeting public neoantigens for cancer immunotherapy.	Nature Cancer	2021
33493502	Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus.	Gastroenterology	2021
33491650	Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer.	Elife	2021
34290408	Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.	Nature	2021
34114951	Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection.	Elife	2021
33731480	Targeting loss of heterozygosity for cancer-specific immunotherapy.	Proceedings of the National Academy of Sciences of the United States of America	2021
33941929	Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands.	Nature Biotechnology	2021
33566109	Association of Î±1-Blocker Receipt With 30-Day Mortality and Risk of Intensive Care Unit Admission Among Adults Hospitalized With Influenza or Pneumonia in Denmark.	JAMA Netw Open	2021
33939694	Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.	PLoS Medicine	2021
33869251	The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality From COVID-19.	Front Med (Lausanne)	2021
33649188	TCR Î² chain-directed bispecific antibodies for the treatment of T cell cancers.	Sci Transl Med	2021
33649166	Targeting a neoantigen derived from a common mutation.	Science	2021
33649101	Bispecific antibodies targeting mutant neoantigens.	Science immunology	2021
32984952	Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.	International Journal of Cancer	2021
33398294	The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19.	medRxiv	2021
34676374	Targeting public neoantigens for cancer immunotherapy.	Nature Cancer	2021
34608287	Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.	Nature	2021
34489470	Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.	Nature Communications	2021
31358460	Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation.	Diagnostic and interventional imaging	2020
32075918	Assessing aneuploidy with repetitive element sequencing.	Proc Natl Acad Sci U S A	2020
31629672	Deep lessons learned: Radiology, oncology, pathology, and computer science experts unite around artificial intelligence to strive for earlier pancreatic cancer diagnosis.	Diagnostic and interventional imaging	2020
32352407	Preventing cytokine storm syndrome in COVID-19 using Î±-1 adrenergic receptor antagonists.	J Clin Invest	2020
32239186	Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-Reply.	JAMA Oncology	2020
31882448	Revisiting the tumorigenesis timeline with a data-driven generative model.	Proc Natl Acad Sci U S A	2020
32345712	Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.	Science	2020
32446597	Erratum to "Annotated normal CT data of the abdomen for deep learning: Challenges and strategies for implementation" [Diagn. Interv. Imaging. 101 (2020) 35-44].	Diagnostic and interventional imaging	2020
31482302	Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.	Virchows Archiv	2020
31548407	Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence.	Proc Natl Acad Sci U S A	2019
31690625	An engineered antibody fragment targeting mutant Î²-catenin via major histocompatibility complex I neoantigen presentation.	Journal of Biological Chemistry	2019
31621801	Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.	JAMA Oncology	2019
30447301	Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.	Human Pathology	2019
30628066	The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations.	International Journal of Cancer	2019
31527070	Direct Detection and Quantification of Neoantigens.	Cancer Immunology Research	2019
31492412	Application of Deep Learning to Pancreatic Cancer Detection: Lessons Learned From Our Initial Experience.	Journal of the American College of Radiology	2019
31028363	Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.	Modern Pathology	2019
31455892	An analysis of genetic heterogeneity in untreated cancers.	Nature Reviews Cancer	2019
31276589	p53: a tumor suppressor hiding in plain sight.	Journal of Molecular Cell Biology	2019
30744692	Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1.	J Immunother Cancer	2019